226 related articles for article (PubMed ID: 32506121)
1. The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia.
Ulivieri M; Wierońska JM; Lionetto L; Martinello K; Cieslik P; Chocyk A; Curto M; Di Menna L; Iacovelli L; Traficante A; Liberatore F; Mascio G; Antenucci N; Giannino G; Vergassola M; Pittaluga A; Bruno V; Battaglia G; Fucile S; Simmaco M; Nicoletti F; Pilc A; Fazio F
Schizophr Bull; 2020 Dec; 46(6):1471-1481. PubMed ID: 32506121
[TBL] [Abstract][Full Text] [Related]
2. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors.
Fazio F; Lionetto L; Molinaro G; Bertrand HO; Acher F; Ngomba RT; Notartomaso S; Curini M; Rosati O; Scarselli P; Di Marco R; Battaglia G; Bruno V; Simmaco M; Pin JP; Nicoletti F; Goudet C
Mol Pharmacol; 2012 May; 81(5):643-56. PubMed ID: 22311707
[TBL] [Abstract][Full Text] [Related]
3. Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors.
Fazio F; Lionetto L; Curto M; Iacovelli L; Copeland CS; Neale SA; Bruno V; Battaglia G; Salt TE; Nicoletti F
Neuropharmacology; 2017 Jan; 112(Pt B):365-372. PubMed ID: 27342123
[TBL] [Abstract][Full Text] [Related]
4. mGlu
Maksymetz J; Byun NE; Luessen DJ; Li B; Barry RL; Gore JC; Niswender CM; Lindsley CW; Joffe ME; Conn PJ
Cell Rep; 2021 Nov; 37(5):109950. PubMed ID: 34731619
[TBL] [Abstract][Full Text] [Related]
5. Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.
Sathyasaikumar KV; Stachowski EK; Wonodi I; Roberts RC; Rassoulpour A; McMahon RP; Schwarcz R
Schizophr Bull; 2011 Nov; 37(6):1147-56. PubMed ID: 21036897
[TBL] [Abstract][Full Text] [Related]
6. Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Fazio F; Zappulla C; Notartomaso S; Busceti C; Bessede A; Scarselli P; Vacca C; Gargaro M; Volpi C; Allegrucci M; Lionetto L; Simmaco M; Belladonna ML; Nicoletti F; Fallarino F
Neuropharmacology; 2014 Jun; 81():237-43. PubMed ID: 24565643
[TBL] [Abstract][Full Text] [Related]
7. Xanthurenic Acid Activates mGlu2/3 Metabotropic Glutamate Receptors and is a Potential Trait Marker for Schizophrenia.
Fazio F; Lionetto L; Curto M; Iacovelli L; Cavallari M; Zappulla C; Ulivieri M; Napoletano F; Capi M; Corigliano V; Scaccianoce S; Caruso A; Miele J; De Fusco A; Di Menna L; Comparelli A; De Carolis A; Gradini R; Nisticò R; De Blasi A; Girardi P; Bruno V; Battaglia G; Nicoletti F; Simmaco M
Sci Rep; 2015 Dec; 5():17799. PubMed ID: 26643205
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia.
Réus GZ; Becker IRT; Scaini G; Petronilho F; Oses JP; Kaddurah-Daouk R; Ceretta LB; Zugno AI; Dal-Pizzol F; Quevedo J; Barichello T
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():55-63. PubMed ID: 29030243
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.
Bortz DM; Wu HQ; Schwarcz R; Bruno JP
Neuropharmacology; 2017 Jul; 121():69-78. PubMed ID: 28419874
[TBL] [Abstract][Full Text] [Related]
10. Mutual activation of glutamatergic mGlu
Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM
Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675
[TBL] [Abstract][Full Text] [Related]
11. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
[TBL] [Abstract][Full Text] [Related]
12. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.
Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A
Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
Amargós-Bosch M; Adell A; Artigas F
J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?
Ghose S; Gleason KA; Potts BW; Lewis-Amezcua K; Tamminga CA
Am J Psychiatry; 2009 Jul; 166(7):812-20. PubMed ID: 19487395
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical and behavioral studies on the 5-HT
Woźniak M; Gołembiowska K; Noworyta-Sokołowska K; Acher F; Cieślik P; Kusek M; Tokarski K; Pilc A; Wierońska JM
Neuropharmacology; 2017 Mar; 115():149-165. PubMed ID: 27465045
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor.
Hikichi H; Hiyoshi T; Marumo T; Tomishima Y; Kaku A; Iida I; Urabe H; Tamita T; Yasuhara A; Karasawa J; Chaki S
J Pharmacol Sci; 2015 Mar; 127(3):352-61. PubMed ID: 25837934
[TBL] [Abstract][Full Text] [Related]
17. Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia.
Jiao S; Li N; Cao T; Wang L; Chen H; Lin C; Cai H
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111011. PubMed ID: 38642730
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia.
Ohnuma T; Augood SJ; Arai H; McKenna PJ; Emson PC
Brain Res Mol Brain Res; 1998 May; 56(1-2):207-17. PubMed ID: 9602129
[TBL] [Abstract][Full Text] [Related]
19. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
20. A Review on the Role and Function of Cinnabarinic Acid, a "Forgotten" Metabolite of the Kynurenine Pathway.
Gawel K
Cells; 2024 Mar; 13(5):. PubMed ID: 38474418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
